Search details
1.
Providing 0.1 Full-Time Equivalent (FTE) Support to Fellowship Core Faculty Improves Faculty Involvement in Fellowship Education and Recruitment.
J Cancer Educ
; 39(3): 325-334, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38430454
2.
Population pharmacokinetic modelling of tremelimumab in patients with advanced solid tumours and the impact of disease status on time-varying clearance.
Br J Clin Pharmacol
; 89(5): 1601-1616, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36454221
3.
Comparative efficacy of chemoimmunotherapy versus immunotherapy for advanced non-small cell lung cancer: A network meta-analysis of randomized trials.
Cancer
; 127(5): 709-719, 2021 03 01.
Article
in English
| MEDLINE | ID: mdl-33119177
4.
Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis.
J Neurooncol
; 154(2): 197-203, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34351544
5.
Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial.
Lancet Oncol
; 21(5): 655-663, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32251621
6.
The end of the beginning: progress and next steps in KRAS-mutant non-small-cell lung cancer.
Lancet
; 401(10378): 706-707, 2023 03 04.
Article
in English
| MEDLINE | ID: mdl-36774937
7.
Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study.
Radiology
; 289(3): 862-870, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30226453
8.
Bullous disorders associated with anti-PD-1 and anti-PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy.
J Am Acad Dermatol
; 79(6): 1081-1088, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-30025829
9.
Yale Precision Medicine Tumor Board: reawakening the guardian of the genome.
Lancet Oncol
; 23(3): 337-338, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35240081
10.
Comparing available criteria for measuring brain metastasis response to immunotherapy.
J Neurooncol
; 132(3): 479-485, 2017 05.
Article
in English
| MEDLINE | ID: mdl-28275886
11.
Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
Lancet Oncol
; 17(3): 299-308, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-26858122
12.
Yale Cancer Center Precision Medicine Tumor Board: molecular findings alter a diagnosis and treatment plan.
Lancet Oncol
; 22(3): 306-307, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33662283
13.
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Lancet Oncol
; 17(7): 976-983, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27267608
14.
Patient preferences regarding incidental genomic findings discovered during tumor profiling.
Cancer
; 122(10): 1588-97, 2016 May 15.
Article
in English
| MEDLINE | ID: mdl-26970385
15.
Correction to: Incidence and characteristics of metastatic intracranial lesions in stage III and IV melanoma: a single institute retrospective analysis.
J Neurooncol
; 154(2): 205, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-34403041
16.
Yale Cancer Center Precision Medicine Tumor Board: new technology, new drugs, and the value of repeat testing.
Lancet Oncol
; 21(3): 343-344, 2020 03.
Article
in English
| MEDLINE | ID: mdl-32950226
17.
Yale Cancer Center Precision Medicine Tumor Board: one tumour, multiple targets.
Lancet Oncol
; 19(12): 1567-1568, 2018 Dec.
Article
in English
| MEDLINE | ID: mdl-32956641
18.
Introduction to the Yale Precision Medicine Tumor Board.
Lancet Oncol
; 19(1): 19-20, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29304351
19.
Yale Cancer Center Precision Medicine Tumor Board: two patients, one targeted therapy, different outcomes.
Lancet Oncol
; 19(1): 23-24, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29304353
20.
Navigating the Complexities of Brain Metastases Management.
Am Soc Clin Oncol Educ Book
; 44(3): e433694, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38781565